TSX open
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/NASDAQ/DXCM

DexCom Inc (DXCM : NASDAQ)

Common Stock

$89.53

USD

+0.36 (0.40%)

Last updated: 2026-09-22

Follow DXCM

DXCM

DexCom Inc

Source:WealthAwesomeWealthAwesome
$0.00 (0.00%)
30 day period
$83.03$87.69$92.34Aug 11Sep 1Sep 22

Performance

1 Day

+0.40%

1 Week

+3.56%

1 Month

-3.04%

YTD

+25.69%

Key Statistics

Market Cap

$33.79B

52W High

$92.59

52W Low

$54.11

P/E Ratio

35.39

50 Day MA

$84.13

200 Day MA

$72.12

Beta

1.42

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/22/2026$89.12$90.39$88.18$89.53$89.537,190,879
9/21/2026$88.83$89.68$88.33$89.17$89.173,453,838
9/18/2026$87.83$89.92$87.39$89.35$89.3514,573,000
9/17/2026$87.54$88.26$87.17$87.93$87.932,816,275
9/16/2026$86.05$88.79$86.05$87.34$87.343,526,590
9/15/2026$84.04$87.36$83.25$86.45$86.455,961,138
9/14/2026$83.92$84.98$83.76$84.68$84.682,540,890
9/11/2026$84.65$85.81$82.83$83.03$83.032,547,398
9/10/2026$83.27$84.82$82.29$84.51$84.513,539,800
9/9/2026$83.93$85.16$82.80$83.88$83.884,177,200

Analyst Price Targets

Based on 27 analysts covering DXCM · as of Sep 21, 2026

📈

Wall Street analysts forecast DXCM stock price to rise 5.5% over the next 12 months.

Consensus

Strong Buy

4.67 / 5.00

Avg. Target

US$94.48

+5.5% Upside

Previously US$94.12 on Sep 17, 2026

Current Price

US$89.53

Last close

Analyst Breakdown (27 analysts)

Strong Buy 21
Buy 3
Hold 3
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on DXCM's historical volatility

HistoricalForecast68%95%
US$65.33US$81.57US$97.81US$114.06US$130.30US$146.54TodayJun 17Aug 5Sep 22Nov 4Dec 18Jan 30

30-Day Vol

23.8%

Annualized

90-Day Vol

41.0%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

US$107.03

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$95.02US$87.53US$103.16
60 trading daysUS$100.85US$89.79US$113.27
90 trading daysUS$107.03US$92.84US$123.40

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Financials

Revenue (TTM)
$4.97B
EBITDA
$1.40B
Profit Margin
20.12%
ROE (TTM)
38.49%
EPS (Diluted)
2.53
Book Value
6.95

Classification

Sector
Health Care
Industry
Health Care Equipment & Supplies
Group
Health Care Equipment & Services

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About DXCM.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
LHSWLianhe Sowell International Group Ltd Ordinary Shares$0.89+105.33%
KFIIRK&F Growth Acquisition Corp. II Rights$0.09+73.36%
ZEOZeo Energy Corp.$0.49+57.04%
RAINRain Enhancement Technologies Holdco, Inc. Class A Common Stock$1.02+54.31%
NBRGRNewbridge Acquisition Limited Rights$0.36+53.19%
GRMLGreenland Mines Ltd$14.15+50.21%
CWDCaliberCos Inc. Class A Common Stock$0.73+40.33%
FLNAFilana Therapeutics, Inc.$1.03+39.28%

DXCM.US news timeline

2 articles covering DXCM.US, most recent first

Latest

Why Dexcom stock is tanking today

Stocks

Advertisement